¾Ï Ä¡·áÁ¦ ½ÃÀå : À¯Åë ä³Îº°, ¾àÁ¦ À¯Çüº°, ¾Ï À¯Çüº°, Ä¡·á¹ýº°, Åõ¿© °æ·Îº°, Áö¿ªº°
Oncology Drugs Market, By Distribution Channel, Drug Type, Cancer Type, By Therapy, By Route of Administration, By Geography
»óǰÄÚµå : 1672726
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,511,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 10,128,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,469,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ¾Ï Ä¡·áÁ¦ ½ÃÀåÀº 2025³â¿¡´Â 2,612¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. 2032³â¿¡´Â 6,073¾ï 6,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2032³â¿¡ °ÉÃÄ CAGR 12.8%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ ¼¼ºÎÁ¤º¸
±âÁØ ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 2,612¾ï 2,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£(2025-2032³â) CAGR 12.80% 2032³â ±Ý¾× ¿¹Ãø 6,073¾ï 6,000¸¸ ´Þ·¯
±×¸². ¾Ï Ä¡·áÁ¦ ½ÃÀå Á¡À¯À²(%), 2025³â, Áö¿ªº°
Oncology Drugs Market-IMG1

¾Ï Ä¡·áÁ¦¶õ ¾Ï¼º Á¾¾çÀÇ Ä¡·á¿¡ »ç¿ëµÇ´Â ÀǾàǰÀ» ¸»ÇÕ´Ï´Ù. ¼¼°èÀÇ ¾Ï Ä¡·áÁ¦ ½ÃÀåÀº ´Ù¾çÇÑ À¯ÇüÀÇ ¾ÏÀÇ À¯º´·üÀÌ »ó½ÂÇϰí Àֱ⠶§¹®¿¡ Áö³­ ¸î ³â°£ ²ÙÁØÇÑ ¼ºÀåÀ» ÀÌ·ê °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é ¾Ï ÀÌȯÀ²Àº 2000³â ÀÌÈÄ °ÅÀÇ µÎ¹è·Î ´Ã¾úÀ¸¸ç, 2040³â±îÁö Àü ¼¼°èÀûÀ¸·Î 50% Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Æó¾Ï, ´ëÀå¾Ï, À¯¹æ¾Ï, Àü¸³¼±¾Ï µîÀÇ ÀÌȯÀ² Áõ°¡°¡ ¾Ï Ä¡·áÁ¦ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ¶ÇÇÑ ³ëÀÎ Áõ°¡¿Í ´ã¹èÀÇ Èí¿¬, À½ÁÖ, ½Ä»ýȰÀÇ È¥¶õ, ¿îµ¿ ºÎÁ· µî »ýȰ ½À°üÀÇ º¯È­µµ ¾Ï ¹ßº´ À§ÇèÀ» ³ô¿© ¾Ï Ä¡·áÁ¦ÀÇ ¸ÅÃâÀ» Áõ´ë½Ã۰í ÀÖ½À´Ï´Ù. »õ·Î¿î ¾à¹° ºÐÀÚ¿Í Ä¡·á¹ýÀÇ °­·ÂÇÑ ÆÄÀÌÇÁ¶óÀΰú Ç¥Àû ¿ä¹ýÀÇ ÃâÇöÀº ½ÃÀå È®´ë¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª, Ä¡·áºñÀÇ ³ôÀ̰¡ ¿©ÀüÈ÷ º´¸ñÀÌ µÇ°í ÀÖ¾î, ¾Ï Ä¡·áÁ¦ÀÇ Æø³ÐÀº º¸±ÞÀ» ¾ïÁ¦Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

¼¼°èÀÇ ¾Ï Ä¡·áÁ¦ ½ÃÀåÀº ¼¼°è¿¡¼­ ´Ù¾çÇÑ ¾ÏÁ¾ÀÇ À¯º´·üÀÌ »ó½ÂÇϰí ÀÖ´Â °ÍÀÌ °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ¼¼°èÀÇ ¾Ï Åë°è¸¦ Á¦½ÃÇÏ´Â ÀÎÅÍ·¢Æ¼ºêÇÑ À¥ ±â¹Ý Ç÷§ÆûÀÎ GLOBOCAN¿¡ µû¸£¸é 2020³â¿¡´Â ¼¼°è¿¡¼­ ¾à 1,930¸¸¸íÀÇ ¾Ï ȯÀÚ°¡ »õ·Ó°Ô ¹ß»ýÇØ, 1,000¸¸¸íÀÌ »ç¸ÁÇß½À´Ï´Ù. Æó¾ÏÀº ¿©ÀüÈ÷ ¾ÏÀ¸·Î ÀÎÇÑ »ç¸Á ¿øÀÎÀÇ °¡Àå Å« ¿øÀÎÀÔ´Ï´Ù. Ç¥Àû Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í Á¦³×¸¯ ÀǾàǰÀÇ ¿ëÀÌÇÑ ÀÔ¼ö´Â ½ÃÀå¿¡ Å« ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ±×·¯³ª, ¾ö°ÝÇÑ ±ÔÁ¦ ½ÃÃ¥, ½ÃÀå °³Ã´¿¡ Á¦¾àÀÌ µÇ´Â ³ôÀº R&D ºñ¿ë, ÀÓ»ó °Ë»ç¿¡¼­ÀÇ ½ÇÆÐ Áõ°¡ µîÀÌ ½ÃÀå ¼ºÀåÀÇ ¾ïÁ¦¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ºí·Ï¹ö½ºÅÍ ÀǾàǰÀÇ Æ¯Çã ¸¸·áÀº ´ë±â¾÷ÀÇ ¼öÀÍ¿¡ ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ½ÅÈï ½ÃÀåÀº ÀÎÁöµµ Çâ»ó, ÀÇ·á ÁöÃâ Áõ°¡, °íǰÁú ¾Ï Ä¡·áÁ¦¿¡ ´ëÇÑ ¼ö¿ä¿¡ °ßÀεǾî ÇâÈÄ °¡´É¼ºÀ» Á¦°øÇÔÀ¸·Î½á »õ·Î¿î ±æÀ» °³Ã´Çϰí ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç

Á¦2Àå ½ÃÀå ¿¹Ãø

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ ¾Ï Ä¡·áÁ¦ ½ÃÀå - Äڷγª ¹ÙÀÌ·¯½º(COVID-19) À¯ÇàÀÇ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ¾Ï Ä¡·áÁ¦ ½ÃÀå, ¾àÁ¦ À¯Çüº°(2020-2032³â), 10¾ï ´Þ·¯

Á¦6Àå ¼¼°èÀÇ ¾Ï Ä¡·áÁ¦ ½ÃÀå, ¾Ï À¯Çüº°(2020-2032³â), 10¾ï ´Þ·¯

Á¦7Àå ¼¼°èÀÇ ¾Ï Ä¡·áÁ¦ ½ÃÀå, Ä¡·á¹ýº°(2020-2032³â), 10¾ï ´Þ·¯

Á¦8Àå ¼¼°èÀÇ ¾Ï Ä¡·áÁ¦ ½ÃÀå, Åõ¿© °æ·Îº°(2020-2032³â), 10¾ï ´Þ·¯

Á¦9Àå ¼¼°èÀÇ ¾Ï Ä¡·áÁ¦ ½ÃÀå, À¯Åë ä³Îº°(2020-2032³â), 10¾ï ´Þ·¯

Á¦10Àå ¼¼°èÀÇ ¾Ï Ä¡·áÁ¦ ½ÃÀå, Áö¿ªº°(2020-2032³â), 10¾ï ´Þ·¯

Á¦11Àå °æÀï ±¸µµ

Á¦12Àå ¾Ö³Î¸®½ºÆ®ÀÇ ½ÃÁ¡

Á¦13Àå Âü°í¹®Çå°ú Á¶»ç¹æ¹ý

KTH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Oncology Drugs Market is estimated to be valued at USD 261.22 Bn in 2025 and is expected to reach USD 607.36 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.8% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 261.22 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 12.80% 2032 Value Projection: USD 607.36 Bn
Figure. Oncology Drugs Market Share (%), By Region 2025
Oncology Drugs Market - IMG1

Oncology drugs refer to medications that are used for treating cancerous tumors. The global oncology drugs market has been witnessing steady growth over the past few years owing to the rising prevalence of various types of cancers. According to the World Health Organization, the cancer burden has nearly doubled since 2000 and is expected to grow by 50% globally by 2040. The increasing incidences of lung cancer, colorectal cancer, breast cancer, and prostate cancer are the major factors fueling the demand for oncology drugs. Furthermore, the growing geriatric population and changing lifestyle habits such as tobacco smoking, alcohol consumption, poor diet, and lack of physical activity have also raised the risk of developing cancer which has augmented the sales of oncology medications. A robust pipeline of novel drug molecules and therapies along with the emergence of targeted therapies are further catalyzing market expansion. However, high treatment cost remains a bottleneck, restraining the broader adoption of cancer medications.

Market Dynamics:

The global oncology drugs market is driven by the rising prevalence of various cancer types worldwide. As per GLOBOCAN, an interactive web-based platform presenting global cancer statistics, there were around 19.3 million new cancer cases and 10 million cancer deaths globally in 2020. Lung cancer remains the leading cause of cancer death. The increasing demand for targeted therapies and easy availability of generic medications are providing huge growth opportunities in the market. However, factors such as stringent regulatory policies, high R&D costs involved in drug development, and frequent drug failures in clinical trials are impeding the market growth. Furthermore, patent expiry of blockbuster drugs is negatively impacting the revenues of major players. Nonetheless, emerging markets in Asia Pacific are opening up new avenues by offering potential future opportunities driven by growing awareness, healthcare spending, and demand for quality cancer treatment.

Key Features of the Study:

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Preview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Oncology Drugs Market - Impact of Coronavirus (COVID-19) Pandemic:

5. Global Oncology Drugs Market, By Drug Type, 2020 - 2032, (USD BN)

6. Global Oncology Drugs Market, By Cancer Type,2020 - 2032, (USD BN)

7. Global Oncology Drugs Market, By Therapy, 2020 - 2032, (USD BN)

8. Global Oncology Drugs Market, By Route of Administration, 2020 - 2032, (USD BN)

9. Global Oncology Drugs Market, By Distribution Channel, 2020 - 2032, (USD BN)

10. Global Oncology Drugs Market, By Region, 2020 - 2032, (USD BN)

11. Competitive Landscape

12. Analyst View

13. References and Research Methodology

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â